RecruitingNot ApplicableNCT07088302

Effect OF Lactase Enzyme Supplements ON Intolerance IN Preterm Neonates

Effect OF Lactase Enzyme Supplements ON Protection Against Feeding Intolerance IN Preterm Neonates

Sponsor

Alexandria University

Enrollment

120 participants

Start Date

Aug 30, 2025

Study Type

INTERVENTIONAL

Conditions

Premature Feeding Disorders Lactase Deficiency, Congenital

Summary

This study aims to study the effect of lactase enzyme in preventing feeding intolerance in preterm neonates in neonatal intensive care unit at Alexandria University Children's Hospital.

Eligibility

Min Age: 3 DaysMax Age: 1 Month

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called lactase administration and placebo for people with feeding disorders, lactase deficiency, congenital, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 3 Days to 1 Month.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.